466
Views
35
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era

, , , &
Pages 381-385 | Received 31 May 2011, Accepted 18 Aug 2011, Published online: 24 Oct 2011

References

  • Carbone PP, Kaplan HS, Musshoff K, . Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860–1861.
  • Lister TA, Crowther D, Sutcliffe SB, . Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswold meeting. J Clin Oncol 1989;7:1630–1636.
  • Franco V, Tripodo C, Rizzo A, . Bone marrow biopsy in Hodgkin's lymphoma. Eur J Haematol 2004;73:149–155.
  • Engert A, Diehl V, Franklin J, . Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 2009;27:4548–4554.
  • Brunning RD, Bloomfield CD, McKenna RW, . Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975;82:365–366.
  • Bain BJ. Bone marrow biopsy morbidity and mortality: 2002 data. Clin Lab Haematol 2004;26:315–318.
  • Juweid ME, Stroobants S, Hoekstra OS, . Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of International Harmonisation Project in Lymphoma. J Clin Oncol 2007;25:571–578.
  • Cheson BD, Pfistner B, Juweid ME, . Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
  • Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med 2005;46:1356–1367.
  • Gallamini A, Hutchings M, Rigacci L, . Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:a report from a joint Italian-Danish study. J Clin Oncol 2007;25:3746–3752.
  • Hutchings M, Loft A, Hansen M, . Positron emission tomography with or without computerized tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006;91:482–489.
  • Pelosi E, Penna D, Deandreis D, . FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Q J Nucl Med Mol Imaging 2008;52:9–16.
  • Pakos E, Fotopoulos A, Ioannidis J. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 2005;46:958–963.
  • Shulkin B, Goodin G, McCarville M, . Bone and 18fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 2009;50:1794–1802.
  • Elstrom R, Tsai D, Vergilio J, . Enhanced marrow 18fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma 2004;5:62–64.
  • Moog F, Bangerter M, Kotzerke J, . 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 1998;16:603–609.
  • Carr R, Barrington S, Madan B, . Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998;91:3340–3346.
  • Jerusalem G, Beguin Y, Fassotte M-F, . Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkins disease. Haematologica 2001;86:266–273.
  • Elstrom R, Guan L, Baker G, . Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101:3875–3876.
  • Munker R, Glass J, Griffeth LK, . Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease. Ann Oncol 2004;15:1699–1704.
  • Kabickova E, Sumerauer D, Cumlivska E, . Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Eur J Nucl Med Mol Imaging 2006;33:1025–1031.
  • Rigacci L, Vitolo U, Nassi L, . Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Ann Haematol 2007;86:897–903.
  • Cerci JJ, Pracchia LF, Junior JS, . Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of Hodgkin lymphoma: a single center experience in Brazil. Clinics 2009;64:491–498.
  • Moulin-Romsee G, Hindie E, Cuenca X, . 18F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010;37:1095–1105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.